Holocene Advisors’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-222,789
| Closed | -$47.1M | – | 832 |
|
|
2026
Q1 | $47.1M | Sell |
222,789
-766,704
| -77% | -$165M | 0.11% | 188 |
|
|
2025
Q4 | $203M | Sell |
989,493
-936,677
| -49% | -$176M | 0.43% | 60 |
|
|
2025
Q3 | $302M | Buy |
1,926,170
+1,128,358
| +141% | +$174M | 0.69% | 37 |
|
|
2025
Q2 | $134M | Sell |
797,812
-187,664
| -19% | -$27.9M | 0.33% | 84 |
|
|
2025
Q1 | $136M | Buy |
985,476
+849,456
| +625% | +$108M | 0.4% | 76 |
|
|
2024
Q4 | $16.1M | Buy |
+136,020
| New | +$15.9M | 0.05% | 267 |
|
|
2024
Q3 | – | Sell |
-600,594
| Closed | -$59.1M | – | 725 |
|
|
2024
Q2 | $59.1M | Sell |
600,594
-402,826
| -40% | -$41M | 0.25% | 122 |
|
|
2024
Q1 | $112M | Buy |
1,003,420
+736,257
| +276% | +$79.4M | 0.41% | 77 |
|
|
2023
Q4 | $26.9M | Sell |
267,163
-532,922
| -67% | -$52.9M | 0.1% | 198 |
|
|
2023
Q3 | $69.5M | Buy |
800,085
+346,905
| +77% | +$31.4M | 0.3% | 103 |
|
|
2023
Q2 | $42.9M | Buy |
+453,180
| New | +$38.3M | 0.18% | 147 |
|
|
2022
Q2 | – | Sell |
-50,181
| Closed | -$2.85M | – | 833 |
|
|
2022
Q1 | $2.85M | Sell |
50,181
-80,011
| -61% | -$4.29M | 0.01% | 408 |
|
|
2021
Q4 | $6.7M | Sell |
130,192
-15,014
| -10% | -$736K | 0.03% | 271 |
|
|
2021
Q3 | $7.18M | Buy |
145,206
+49,206
| +51% | +$2.67M | 0.04% | 277 |
|
|
2021
Q2 | $5.48M | Sell |
96,000
-19,496
| -17% | -$1.14M | 0.03% | 332 |
|
|
2021
Q1 | $7.02M | Buy |
115,496
+68,540
| +146% | +$3.78M | 0.04% | 308 |
|
|
2020
Q4 | $2.52M | Buy |
46,956
+11,533
| +33% | +$598K | 0.02% | 373 |
|
|
2020
Q3 | $1.66M | Sell |
35,423
-5,284
| -13% | -$271K | 0.01% | 416 |
|
|
2020
Q2 | $2.12M | Buy |
40,707
+2,825
| +7% | +$146K | 0.02% | 299 |
|
|
2020
Q1 | $1.82M | Sell |
37,882
-68,984
| -65% | -$3.58M | 0.02% | 295 |
|
|
2019
Q4 | $5.41M | Buy |
106,866
+12,249
| +13% | +$633K | 0.05% | 206 |
|
|
2019
Q3 | $4.46M | Buy |
94,617
+76,695
| +428% | +$3.5M | 0.05% | 167 |
|
|
2019
Q2 | $844K | Buy |
17,922
+11,259
| +169% | +$519K | 0.01% | 326 |
|
|
2019
Q1 | $321K | Sell |
6,663
-543
| -8% | -$27.2K | ﹤0.01% | 527 |
|
|
2018
Q4 | $321K | Buy |
+7,206
| New | +$376K | 0.01% | 552 |
|
|
2018
Q3 | – | Sell |
-10,051
| Closed | -$491K | – | 728 |
|
|
2018
Q2 | $491K | Buy |
10,051
+4,107
| +69% | +$233K | 0.01% | 286 |
|
|
2018
Q1 | $373K | Sell |
5,944
-8,422
| -59% | -$578K | 0.01% | 349 |
|
|
2017
Q4 | $880K | Buy |
+14,366
| New | +$888K | 0.02% | 225 |
|
Other funds holding CAH
Holocene Advisors's CAH Position: Q2 2026 in Review
Holocene Advisors sold out of Cardinal Health (CAH) in Q2 2026, closing a stake of 222,789 shares — an estimated $47.1M sold.
Holocene Advisors first reported a position in CAH in Q4 2017 and held it in 28 quarters. The position peaked at $302M in Q3 2025. 1,494 funds tracked by Wall St. Rank hold CAH as of Q2 2026.
- Holocene Advisors reported no remaining Cardinal Health position as of Q2 2026 after selling out during the quarter.
- Holocene Advisors sold 222,789 Cardinal Health shares in Q2 2026, an estimated $47.1M.
- Holocene Advisors first reported a position in Cardinal Health in Q4 2017 and held it in 28 quarters.
- Holocene Advisors's Cardinal Health position peaked at $302M in Q3 2025.
- 1,494 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.
Based on Holocene Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.